Annual Working Capital
$674.76 M
-$78.21 M-10.39%
December 31, 2024
Summary
- As of March 14, 2025, ABCL annual working capital is $674.76 million, with the most recent change of -$78.21 million (-10.39%) on December 31, 2024.
- During the last 3 years, ABCL annual working capital has fallen by -$134.37 million (-16.61%).
- ABCL annual working capital is now -25.62% below its all-time high of $907.17 million, reached on December 31, 2022.
Performance
ABCL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$674.76 M
+$11.44 M+1.73%
December 31, 2024
Summary
- As of March 14, 2025, ABCL quarterly working capital is $674.76 million, with the most recent change of +$11.44 million (+1.73%) on December 31, 2024.
- Over the past year, ABCL quarterly working capital has increased by +$11.44 million (+1.73%).
- ABCL quarterly working capital is now -29.78% below its all-time high of $960.96 million, reached on March 31, 2022.
Performance
ABCL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ABCL Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.4% | +1.7% |
| 3 y3 years | -16.6% | +1.7% |
| 5 y5 years | +10000.0% | +1.7% |
ABCL Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.6% | at low | -29.8% | +1.7% |
| 5 y | 5-year | -25.6% | >+9999.0% | -29.8% | >+9999.0% |
| alltime | all time | -25.6% | >+9999.0% | -29.8% | >+9999.0% |
AbCellera Biologics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $674.76 M(-10.4%) | $674.76 M(+1.7%) |
| Sep 2024 | - | $663.32 M(-5.4%) |
| Jun 2024 | - | $701.17 M(-1.1%) |
| Mar 2024 | - | $709.07 M(-5.8%) |
| Dec 2023 | $752.97 M(-17.0%) | $752.97 M(-7.0%) |
| Sep 2023 | - | $809.28 M(-0.3%) |
| Jun 2023 | - | $811.83 M(-4.6%) |
| Mar 2023 | - | $851.06 M(-6.2%) |
| Dec 2022 | $907.17 M | $907.17 M(-3.5%) |
| Sep 2022 | - | $939.62 M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $922.82 M(-4.0%) |
| Mar 2022 | - | $960.96 M(+18.8%) |
| Dec 2021 | $809.12 M(+14.0%) | $809.12 M(+7.3%) |
| Sep 2021 | - | $754.20 M(-5.0%) |
| Jun 2021 | - | $794.24 M(-3.1%) |
| Mar 2021 | - | $819.59 M(+15.5%) |
| Dec 2020 | $709.84 M(>+9900.0%) | $709.84 M(+656.0%) |
| Sep 2020 | - | $93.90 M(+1878.8%) |
| Dec 2019 | $4.75 M(-45.6%) | $4.75 M |
| Dec 2018 | $8.73 M | - |
FAQ
- What is AbCellera Biologics annual working capital?
- What is the all time high annual working capital for AbCellera Biologics?
- What is AbCellera Biologics annual working capital year-on-year change?
- What is AbCellera Biologics quarterly working capital?
- What is the all time high quarterly working capital for AbCellera Biologics?
- What is AbCellera Biologics quarterly working capital year-on-year change?
What is AbCellera Biologics annual working capital?
The current annual working capital of ABCL is $674.76 M
What is the all time high annual working capital for AbCellera Biologics?
AbCellera Biologics all-time high annual working capital is $907.17 M
What is AbCellera Biologics annual working capital year-on-year change?
Over the past year, ABCL annual working capital has changed by -$78.21 M (-10.39%)
What is AbCellera Biologics quarterly working capital?
The current quarterly working capital of ABCL is $674.76 M
What is the all time high quarterly working capital for AbCellera Biologics?
AbCellera Biologics all-time high quarterly working capital is $960.96 M
What is AbCellera Biologics quarterly working capital year-on-year change?
Over the past year, ABCL quarterly working capital has changed by +$11.44 M (+1.73%)